Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, nationwide pet pharmacy PetMed Express (PETS -0.48%) has earned a respected four-star ranking.
With that in mind, let's take a closer look at PetMed and see what CAPS investors are saying about the stock right now.
PetMed facts
|
Headquarters (Founded) |
Pompano Beach, Fla. (1996) |
|
Market Cap |
$221.9 million |
|
Industry |
Internet retail |
|
Trailing-12-Month Revenue |
$233.6 million |
|
Management |
CEO Menderes Akdag (since 2001) |
|
Return on Equity (Average, Past 3 Years) |
21.5% |
|
Cash / Debt |
$62.5 million / $0 |
|
Dividend Yield |
5.2% |
|
Competitors |
Amazon.com (AMZN -1.64%) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 97% of the 887 members who have rated PetMed believe the stock will outperform the S&P 500 going forward.
Just yesterday, one of those Fools, hend6, succinctly summed up the PetMed bull case for our community: "A very solid balance sheet, despite a lower year-over-year net income, mixed with a great dividend offering. As more people shift to online ordering, and as the younger generation continues to move out and get pets, services like these are posed to thrive."
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
